{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:05:31Z","timestamp":1790215531230,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,23]]},"DOI":"10.7759\/cureus.116801","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:30:51Z","timestamp":1790213451000},"source":"Crossref","is-referenced-by-count":0,"title":["Concurrent Catastrophic Antiphospholipid Syndrome, Hemophagocytic Lymphohistiocytosis, and Myocarditis Leading to Multi-organ Failure in a Patient With Systemic Lupus Erythematosus and Antiphospholipid Syndrome"],"prefix":"10.7759","author":[{"given":"Shiva","family":"Chauhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maymuna","family":"Suleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/antib13010021","article-title":"Diagnosis and management of catastrophic antiphospholipid syndrome and the potential impact of the 2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"13","author":"Jacobs L","year":"2024","unstructured":"Jacobs L, Wauters N, Lablad Y, Morelle J, Taghavi M. Diagnosis and management of catastrophic antiphospholipid syndrome and the potential impact of the 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Antibodies (Basel). 2024, 13:10.3390\/antib13010021","journal-title":"Antibodies (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.69730","article-title":"Catastrophic antiphospholipid syndrome: a review of current evidence and future management practices","volume":"16","author":"Okunlola AO","year":"2024","unstructured":"Okunlola AO, Ajao TO, Sabi M, Kolawole OD, Eweka OA, Karim A, Adebayo TE. Catastrophic antiphospholipid syndrome: a review of current evidence and future management practices. Cureus. 2024, 16:e69730. 10.7759\/cureus.69730","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010668","article-title":"Catastrophic antiphospholipid syndrome","volume":"25","author":"Bitsadze V","year":"2024","unstructured":"Bitsadze V, Yakubova F, Khizroeva J, et al.. Catastrophic antiphospholipid syndrome. Int J Mol Sci. 2024, 25:10.3390\/ijms25010668","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.22018","article-title":"Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients","volume":"54","author":"Bucciarelli S","year":"2006","unstructured":"Bucciarelli S, Espinosa G, Cervera R, et al.. Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum. 2006, 54:2568-76. 10.1002\/art.22018","journal-title":"Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1590\/s1807-59322009000200003","article-title":"Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients","volume":"64","author":"Salluh JI","year":"2009","unstructured":"Salluh JI, Soares M, De Meis E. Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients. Clinics (Sao Paulo). 2009, 64:79-82. 10.1590\/s1807-59322009000200003","journal-title":"Clinics (Sao Paulo)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1410400","article-title":"Case report: catastrophic antiphospholipid syndrome in a pediatric patient after percutaneous treatment of aortic re-coarctation","volume":"12","author":"Garc\u00eda Herrera IP","year":"2024","unstructured":"Garc\u00eda Herrera IP, Canales Robredo C, Aboytes Zavala M, Merayo Chalico J, Pineda Arzate OS, Col\u00edn Ort\u00edz JL, Aparicio Vera LA. Case report: catastrophic antiphospholipid syndrome in a pediatric patient after percutaneous treatment of aortic re-coarctation. Front Pediatr. 2024, 12:1410400. 10.3389\/fped.2024.1410400","journal-title":"Front Pediatr"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5430\/crim.v3n4p73","article-title":"Catastrophic antiphospholipid syndrome (CAPS) precipitated by cardiac surgery: a case report and review of the literature","volume":"3","author":"Gandhi SJ","year":"2016","unstructured":"Gandhi SJ, Medic I, Lachant NA. Catastrophic antiphospholipid syndrome (CAPS) precipitated by cardiac surgery: a case report and review of the literature. Case Rep Intern Med. 2016, 3:73-7. 10.5430\/crim.v3n4p73","journal-title":"Case Rep Intern Med"},{"key":"ref8","article-title":"The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus","volume":"34","author":"Bayraktar UD","year":"2007","unstructured":"Bayraktar UD, Erkan D, Bucciarelli S, Espinosa G, Asherson R. The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. J Rheumatol. 2007, 34:346-52.","journal-title":"J Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera R","year":"2002","unstructured":"Cervera R, Piette JC, Font J, et al.. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002, 46:1019-27. 10.1002\/art.10187","journal-title":"Arthritis Rheum"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.05.010","article-title":"Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients","volume":"16","author":"Gavand PE","year":"2017","unstructured":"Gavand PE, Serio I, Arnaud L, et al.. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 103 episodes in 89 adult patients. Autoimmun Rev. 2017, 16:743-9. 10.1016\/j.autrev.2017.05.010","journal-title":"Autoimmun Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-247376","article-title":"Rare association of haemophagocytic lymphohistiocytosis (HLH) and antiphospholipid syndrome (APS) in postpartum period: a considerable overlap?","volume":"15","author":"B Rathna R","year":"2022","unstructured":"B Rathna R, Dhali A, Varghese AK, H Balakrishnan C. Rare association of haemophagocytic lymphohistiocytosis (HLH) and antiphospholipid syndrome (APS) in postpartum period: a considerable overlap?. BMJ Case Rep. 2022, 15:10.1136\/bcr-2021-247376","journal-title":"BMJ Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41972","article-title":"A rare rheumatologic case of catastrophic antiphospholipid syndrome","volume":"15","author":"Maheshwari M","year":"2023","unstructured":"Maheshwari M, Athiraman H. A rare rheumatologic case of catastrophic antiphospholipid syndrome. Cureus. 2023, 15:e41972. 10.7759\/cureus.41972","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.6.530","article-title":"Long term outcome of catastrophic antiphospholipid syndrome survivors","volume":"62","author":"Erkan D","year":"2003","unstructured":"Erkan D, Asherson RA, Espinosa G, Cervera R, Font J, Piette JC, Lockshin MD. Long term outcome of catastrophic antiphospholipid syndrome survivors. Ann Rheum Dis. 2003, 62:530-3. 10.1136\/ard.62.6.530","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytac446","article-title":"A case report of acute heart failure and cardiogenic shock caused by catastrophic antiphospholipid syndrome and lupus myocarditis","volume":"6","author":"Lai AC","year":"2022","unstructured":"Lai AC, Feinman J, Oates C, Parikh A. A case report of acute heart failure and cardiogenic shock caused by catastrophic antiphospholipid syndrome and lupus myocarditis. Eur Heart J Case Rep. 2022, 6:ytac446. 10.1093\/ehjcr\/ytac446","journal-title":"Eur Heart J Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae376","article-title":"Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study","volume":"64","author":"Ramirez GA","year":"2025","unstructured":"Ramirez GA, Holopainen NE, Gerosa M, et al.. Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study. Rheumatology (Oxford). 2025, 64:1904-11. 10.1093\/rheumatology\/keae376","journal-title":"Rheumatology (Oxford)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000025591","article-title":"Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: case series and literature review","volume":"100","author":"Meridor K","year":"2021","unstructured":"Meridor K, Shoenfeld Y, Tayer-Shifman O, Levy Y. Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: case series and literature review. Medicine (Baltimore). 2021, 100:e25591. 10.1097\/MD.0000000000025591","journal-title":"Medicine (Baltimore)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.971366","article-title":"Low dose versus standard dose rituximab for the treatment of antiphospholipid syndrome: a pilot study from a tertiary medical center","volume":"13","author":"Gan Y","year":"2022","unstructured":"Gan Y, Zhong X, Zhao Y, Li G, Ye H, Li C. Low dose versus standard dose rituximab for the treatment of antiphospholipid syndrome: a pilot study from a tertiary medical center. Front Immunol. 2022, 13:971366. 10.3389\/fimmu.2022.971366","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1145145","article-title":"An update on the biologics for the treatment of antiphospholipid syndrome","volume":"14","author":"Yun Z","year":"2023","unstructured":"Yun Z, Duan L, Liu X, Cai Q, Li C. An update on the biologics for the treatment of antiphospholipid syndrome. Front Immunol. 2023, 14:1145145. 10.3389\/fimmu.2023.1145145","journal-title":"Front Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key119","article-title":"Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists","volume":"57","author":"Guitton Z","year":"2018","unstructured":"Guitton Z, Terriou L, Lega JC, et al.. Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists. Rheumatology (Oxford). 2018, 57:1432-8. 10.1093\/rheumatology\/key119","journal-title":"Rheumatology (Oxford)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001083","article-title":"Eltrombopag: efficacy and safety in steroid refractory lupus-associated immune thrombocytopenia","volume":"26","author":"Shobha V","year":"2020","unstructured":"Shobha V, Sanil S, Roongta R. Eltrombopag: efficacy and safety in steroid refractory lupus-associated immune thrombocytopenia. J Clin Rheumatol. 2020, 26:274-8. 10.1097\/RHU.0000000000001083","journal-title":"J Clin Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/434550-concurrent-catastrophic-antiphospholipid-syndrome-hemophagocytic-lymphohistiocytosis-and-myocarditis-leading-to-multi-organ-failure-in-a-patient-with-systemic-lupus-erythematosus-and-antiphospholipid-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T01:30:52Z","timestamp":1790213452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/434550-concurrent-catastrophic-antiphospholipid-syndrome-hemophagocytic-lymphohistiocytosis-and-myocarditis-leading-to-multi-organ-failure-in-a-patient-with-systemic-lupus-erythematosus-and-antiphospholipid-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.116801","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,23]]}}}